Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
pembrolizumab
×
Other solid neoplasm
×
Clear all
Filters
3
NCT04301011
2025-04-23
RAPTOR
Turnstone Biologics, Corp.
Phase 1
Terminated
27 enrolled